Fellowship · New Orleans, LA
Sponsored by Louisiana State University School of Medicine
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
JAMA · 2021 · 651 citations · Tamara Bradford
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
The New England journal of medicine · 2021 · 293 citations · Tamara Bradford
Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
The New England journal of medicine · 2022 · 197 citations · Tamara Bradford
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
MMWR. Morbidity and mortality weekly report · 2022 · 229 citations · Tamara Bradford
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022.
MMWR. Morbidity and mortality weekly report · 2022 · 178 citations · Tamara Bradford
BNT162b2 Protection against the Omicron Variant in Children and Adolescents.
The New England journal of medicine · 2022 · 196 citations ·
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
The New England journal of medicine · 2022 · 162 citations · Tamara Bradford
Six-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.
JAMA pediatrics · 2025 · 20 citations · Tamara Bradford, Michelle Sykes